Literature DB >> 8028598

Cell cycle-specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross-linking.

D A Tanguay1, T C Chiles.   

Abstract

The ligation of membrane Ig (mIg) on quiescent primary B lymphocytes by mitogenic concentrations of anti-IgM antibodies leads to cell cycle progression. The level of cyclin-dependent kinase 2 (Cdk2) expression was found to be restricted to specific phases of the cell cycle in primary cultures of murine B lymphocytes. Resting G0 phase, G1 phase, or B cells arrested near the G1/S boundary by hydroxyurea contained no detectable Cdk2 protein or associated histone H1 kinase activity. In contrast, B cell entry into S phase was accompanied by an induction in the expression of cellular Cdk2 as judged by immunoblotting of B cell lysates with anti-Cdk2 antibodies. Concomitant with S phase entry was the detection of anti-Cdk2-specific immunoprecipitable histone H1 kinase activity. Further analysis revealed that the amount of cyclin A protein also oscillated during cell cycle, appearing initially in G1 phase B cells. Cyclin A was found to be associated with Cdk2 in B cells during S phase progression. These results indicate that cross-linking of mIg on primary B lymphocytes results in the "downstream" catalytic activation of Cdk2. The timing of Cdk2 expression and its association with cyclin A suggests that Cdk2 may not be involved in the decision to enter S phase, but rather may provide a role in the maintenance of S phase progression or in preparing B cells to enter M phase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8028598     DOI: 10.1016/0161-5890(94)90173-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Activation of cyclin E-dependent kinase activity in colorectal cancer.

Authors:  W R Cam; T Masaki; T Y Shiratori; N Kato; M Okamoto; Y Yamaji; K Igarashi; T Sano; M Omata
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

3.  Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle.

Authors:  B J Shenker; S Datar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.

Authors:  S A Ezhevsky; H Toyoshima; T Hunter; D W Scott
Journal:  Mol Biol Cell       Date:  1996-04       Impact factor: 4.138

5.  Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.

Authors:  N Solvason; W W Wu; N Kabra; X Wu; E Lees; M C Howard
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 6.  Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.

Authors:  Lucas Le Roy; Anne Letondor; Cloé Le Roux; Ahmed Amara; Serge Timsit
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

7.  Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Authors:  Sean G Rudd; Nikolaos Tsesmetzis; Kumar Sanjiv; Cynthia Bj Paulin; Lakshmi Sandhow; Juliane Kutzner; Ida Hed Myrberg; Sarah S Bunten; Hanna Axelsson; Si Min Zhang; Azita Rasti; Petri Mäkelä; Si'Ana A Coggins; Sijia Tao; Sharda Suman; Rui M Branca; Georgios Mermelekas; Elisée Wiita; Sun Lee; Julian Walfridsson; Raymond F Schinazi; Baek Kim; Janne Lehtiö; Georgios Z Rassidakis; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Mats Heyman; Dan Grandér; Sören Lehmann; Thomas Lundbäck; Hong Qian; Jan-Inge Henter; Torsten Schaller; Thomas Helleday; Nikolas Herold
Journal:  EMBO Mol Med       Date:  2020-01-17       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.